These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

1174 related items for PubMed ID: 8322274

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2. [Arterioarterial shunt coated with collagen. A model of acute arterial thrombosis for testing antithrombotic agents in rats].
    Mantz F, Freund M, Cazenave JP.
    Chirurgie; 1991; 117(9):692-9. PubMed ID: 1843669
    [Abstract] [Full Text] [Related]

  • 3. The antiaggregating and antithrombotic activity of clopidogrel is potentiated by aspirin in several experimental models in the rabbit.
    Herbert JM, Dol F, Bernat A, Falotico R, Lalé A, Savi P.
    Thromb Haemost; 1998 Sep; 80(3):512-8. PubMed ID: 9759636
    [Abstract] [Full Text] [Related]

  • 4. Comparison of the antithrombotic effects of heparin, hirudin and clopidogrel according to the nature of the thrombogenic surface in an arterioarterial shunt in rats.
    Léger P, Magues JP, Freund M, Cazenave JP, Boneu B.
    Thromb Haemost; 1999 Sep; 82(3):1203-4. PubMed ID: 10494794
    [No Abstract] [Full Text] [Related]

  • 5. Effects of a novel platelet nitric oxide donor (LA816), aspirin, clopidogrel, and combined therapy in inhibiting flow- and lesion-dependent thrombosis in the porcine ex vivo model.
    Vilahur G, Segalés E, Salas E, Badimon L.
    Circulation; 2004 Sep 21; 110(12):1686-93. PubMed ID: 15381660
    [Abstract] [Full Text] [Related]

  • 6. Comparison of PD0348292, a selective factor Xa inhibitor, to antiplatelet agents for the inhibition of arterial thrombosis.
    Karnicki K, Leadley RJ, Baxi S, Peterson T, Wysokinski W, McBane RD.
    Thromb Haemost; 2008 Apr 21; 99(4):759-66. PubMed ID: 18392334
    [Abstract] [Full Text] [Related]

  • 7. Correlation between bleeding time and antithrombotic effect of platelet-suppressive agents in rat experimental model.
    Suehiro A, Oura Y, Ueda M, Kakishita E.
    Res Commun Chem Pathol Pharmacol; 1994 Feb 21; 83(2):157-63. PubMed ID: 8202629
    [Abstract] [Full Text] [Related]

  • 8. Comparison of enoxaparin, hirulog, and heparin as adjunctive antithrombotic therapy during thrombolysis with rtPA in the stenosed canine coronary artery.
    Leadley RJ, Kasiewski CJ, Bostwick JS, Bentley R, McVey MJ, White FJ, Perrone MH, Dunwiddie CT.
    Thromb Haemost; 1997 Oct 21; 78(4):1278-85. PubMed ID: 9364998
    [Abstract] [Full Text] [Related]

  • 9. Effect of new synthetic heparin mimetics on whole blood thrombin generation in vivo and in vitro in rats.
    Hérault JP, Bernat A, Gaich C, Herbert M.
    Thromb Haemost; 2002 Feb 21; 87(2):238-44. PubMed ID: 11858483
    [Abstract] [Full Text] [Related]

  • 10. Effects of SanOrg123781A, a synthetic hexadecasaccharide, in a mouse model of electrically induced carotid artery injury: synergism with the antiplatelet agent clopidogrel.
    Lorrain J, Lechaire I, Gauffeny C, Masson R, Roome N, Herault JP, O'Connor SE, Schaeffer P, Herbert JM.
    J Pharmacol Exp Ther; 2004 Apr 21; 309(1):235-40. PubMed ID: 14718579
    [Abstract] [Full Text] [Related]

  • 11. [Inactivated factor VII exercises a powerful antithrombotic activity in an experimental model of recurrent arterial thrombosis].
    Ragni M, Golino P, Cirillo P, Pascucci I, Scognamiglio A, Ravera A, Esposito N, Battaglia C, Guarino A, Chiariello M.
    Cardiologia; 1996 Jan 21; 41(1):51-8. PubMed ID: 8697470
    [Abstract] [Full Text] [Related]

  • 12. The characterisation of thrombus development in an improved model of arterio-venous shunt thrombosis in the rat and the effects of recombinant desulphatohirudin (CGP 39393), heparin, and iloprost.
    Peters RF, Lees CM, Mitchell KA, Tweed MF, Talbot MD, Wallis RB.
    Thromb Haemost; 1991 Mar 04; 65(3):268-74. PubMed ID: 1710836
    [Abstract] [Full Text] [Related]

  • 13. Pharmacological effects of a novel recombinant hirudin, CX-397, in vivo and in vitro: comparison with recombinant hirudin variant-1, heparin, and argatroban.
    Komatsu Y, Inoue Y, Goto Y, Fukazawa T, Hayashi H.
    Thromb Haemost; 1999 Feb 04; 81(2):250-5. PubMed ID: 10064001
    [Abstract] [Full Text] [Related]

  • 14. Discrimination between platelet-mediated and coagulation-mediated mechanisms in a model of complex thrombus formation in vivo.
    Cadroy Y, Horbett TA, Hanson SR.
    J Lab Clin Med; 1989 Apr 04; 113(4):436-48. PubMed ID: 2522978
    [Abstract] [Full Text] [Related]

  • 15. Inhibition of platelet-dependent thrombosis by low molecular weight heparin (CY222): comparison with standard heparin.
    Cadroy Y, Harker LA, Hanson SR.
    J Lab Clin Med; 1989 Oct 04; 114(4):349-57. PubMed ID: 2551985
    [Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17. Arterial antithrombotic effects of aspirin, heparin, enoxaparin and clopidogrel alone, or in combination, in the rat.
    Daykin HJ, Sturgeon SA, Jones C, Wright CE.
    Thromb Res; 2006 Oct 04; 118(6):755-62. PubMed ID: 16410020
    [Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20. Antithrombotic drugs in vascular medicine: a historical perspective.
    Schrör K.
    Semin Vasc Med; 2003 May 04; 3(2):97-105. PubMed ID: 15199472
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 59.